Trials / Unknown
UnknownNCT06334848
Efficacy of Mini Sling Versus Transobturator Tape in Surgical Management of Women With Stress Urinary Incontinence
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (estimated)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- Female
- Age
- 60 Years
- Healthy volunteers
- Accepted
Summary
To compare the efficacy of mini sling against Transobturator tape for surgical management of women with stress urinary incontinence.
Detailed description
Urinary incontinence is defined as involuntary loss of urine and is divided into subtypes according to symptoms. These subtypes include SUI, in which urine loss occurs during exertion, physical exercise, coughing or sneezing; urgency urinary incontinence (UUI), in which urine loss is associated with urinary urgency; and mixed urinary incontinence (MUI), which is characterized by the association of stress loss with urgency. There are non-surgical treatments (e.g., lifestyle modifications, pharmacotherapy, physiotherapy and vaginal pessary) and surgical treatments. As regards sling use, it was found that mid urethral slings techniques achieved high cure rates in women with SUI and have become the mainstay for surgical treatment of SUI in women over the last 2 decades. One of the modalities of such procedures is the transobturator mid urethral tape (TOT). It was introduced to minimize the complications of the previous retropubic tapes, which include injury to the bladder, major vessels, and bowel. In an effort to maintain efficacy while eliminating some of the side effects, a new generation of tapes has been developed, called single incision tapes or mini-slings. They are designed to be shorter in length than standard mid-urethral slings and do not penetrate the tissues as deeply as standard slings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | transobturator tape | Women with stress urinary incontinence are treated by transobturator tape versus mini sling |
Timeline
- Start date
- 2024-04-01
- Primary completion
- 2025-04-01
- Completion
- 2025-09-01
- First posted
- 2024-03-28
- Last updated
- 2024-03-28
Source: ClinicalTrials.gov record NCT06334848. Inclusion in this directory is not an endorsement.